Previous 10 | Next 10 |
Specialty diagnostics company Precipio's shares rise ([[PRPO]] +23.6%) after launching the HemeScreen Anemia Panel as part of its suite of diagnostic tests.The HemeScreen Anemia Panel is a simple blood test that identifies molecular genetic errors which point to potentially fatal acute l...
Laboratories can use this rapid, cost effective test to distinguish malignancy-driven anemia from other causes NEW HAVEN, Conn., June 08, 2021 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO) , announced that it has launched the Hem...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Once left for dead, Precipio Inc. (NASDAQ: PRPO ) has shown big signs of life. Source: iStockphoto Since bottoming out at 58 cents in April 2020, the PRPO stock is now up to $3.71. From here, I’d li...
Precipio, Inc. (PRPO) Q1 2021 Earnings Conference Call May 20, 2021 5:00 P.M. ET Company Participants Ilan Danieli - Chief Executive Officer Conference Call Participants Presentation Operator Good day and welcome to the Precipio’s Shareholder First Quarter 2021 Shareholder Update Confe...
Gainers: Annovis Bio (ANVS) +250%.Jiuzi Holdings (JZXN) +27%.Longeveron (LGVN) +25%.Wah Fu Education (WAFU) +22%.Mesa Royalty Trust (MTR) +20%.Gracell Biotechnologies (GRCL) +20%.Obalon Therapeutics (OBLN) +16%.Yalla Group (YALA) +16%.VOC Energy Trust (VOC) +12%.Cyclo Therapeut...
Gainers: Annovis Bio ANVS +112%, Gracell Biotechnologies (GRCL) +24%, Metacrine MTCR +16%, Sensei Biotherapeutics (SNSE) +14%, Longeveron (LGVN) +12%.Losers: Precipio (PRPO) -12%, Cullinan Oncology CGEM -8%, Navidea Biopharmaceutical...
Precipio (PRPO): Q1 GAAP EPS of -$0.08 beats by $0.02.Revenue of $1.82M (+49.2% Y/Y) misses by $1.43M.Shares -9.5% AH.Press Release For further details see: Precipio EPS beats by $0.02, misses on revenue
Gainers: Big Rock Partners Acquisition (BRPA) +86%.Euro Tech Holdings (CLWT) +32%.Urban One (UONE) +28%.Sensei Biotherapeutics (SNSE) +28%.BBQ Holdings (BBQ) +22%.PDS Biotechnology (PDSB) +20%.Advanced Emissions Solutions (ADES) +19%.Progenity (PROG) +18%.Moxian (MOXC) +16%.Precipio (PRP...
Gainers: Precipio (PRPO) +23%, PDS Biotechnology (PDSB) +20%, Sensei Biotherapeutics (SNSE) +18%, Iovance Biotherapeutics (IOVA) +17%, Tyme Technologies (TYME) +12%.Losers: Black Diamond Therapeutics (BDTX) -30%, Aerpio Pharmaceuticals (A...
3 Penny Stocks To Watch After Crypto News Crashes Digital Asset Prices Penny stocks are well-known for their high-risk nature. But lately, things like bitcoin price and cryptocurrency news have gotten wrapped into the fold. In particular, when cryptos like Dogecoin and Ethereum bega...
News, Short Squeeze, Breakout and More Instantly...
NEW HAVEN, Conn., July 25, 2024 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) , announces that its unaudited non-GAAP Cash Burn/Generated from Operations (CBFO) for Q2-2024 was $0.3M of cash generated for the quarter. It is important to not...
NEW HAVEN, Conn., July 17, 2024 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) , announces that for Q2-2024, its unaudited revenues have grown from $3.4M in Q1-2024 to $4.4M in Q2-2024, an increase of 30% from one quarter ago. Patholog...
NEW HAVEN, Conn., June 13, 2024 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO) , today announced that the company’s 2024 Annual Meeting of Shareholders (“Annual Meeting”) was convened and adjourned, without any business being conducted...